Value-Based Care

Merz Aesthetics secures key EU approvals for its BELOTERO® Balance filler, offering a precise, evidence-backed solution for tired eyes and forehead lines.

With a massive new investment led by NewSpring, physician-led Honest Health is set to expand its mission of transforming healthcare from volume to value.

Japan becomes the first nation outside Israel to approve Alpha DaRT, a highly precise therapy for untreatable head and neck cancers. Here’s what it means.

Verdiva Bio's VRB-101 aims to be the first once-weekly oral GLP-1, a potential game-changer for patients tired of daily pills and injections.

Fresh off strong 2025 earnings, AtriCure will detail its growth strategy and innovative cardiac portfolio at a major life sciences conference.

A pivotal trial for a rare muscle disease failed its main goal, but promising data in a specific patient group offers a new, complex path forward.

With its Moda-flx system cleared by the FDA, Diality hires M&A expert Peter Donato to navigate the path to commercialization in the $92B dialysis market.

As Legacy Community Health embarks on a historic expansion, new COO Aaron Stewart is tasked with steering Texas's largest FQHC to serve more communities.

The AI health platform's latest acquisition integrates a specialized pregnancy app, promising a new era of proactive, data-driven maternal care for families.

With a $60M Series A, Chamber Cardio is using AI and risk-sharing to move cardiology to a value-based model, aiming to fix America's costliest disease.

Wolters Kluwer's UpToDate again tops KLAS rankings, highlighting a major trend: integrating expert-backed patient education directly into clinical care.

A new partnership will leverage advanced technology to transform care for thousands of Medicare patients, aiming for better outcomes and lower costs.

RAAPID’s award-winning Neuro-Symbolic AI brings transparency to risk adjustment, promising audit-ready accuracy and major ROI for value-based care.

A new report projects a staggering $47T cost from chronic illness by 2039. Experts say prevention and innovation could save trillions and 13.5M lives.

Providence Care's new CEO is a former therapist. Can his clinical insight solve market challenges and deliver on a private equity growth plan?